arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

CNS Pharmaceuticals, Inc.

CNSP

$5.46 0.00 (0.00%) at close

34 Visible periods

21 Metrics

Absolute Benchmarks

Price Chart

Health

Poor

Bearish Absolute basis

auto_awesome

Analytical Summary

On an absolute basis, CNS Pharmaceuticals, Inc. shows weak fundamentals, weighed down by Return on Invested Capital and Interest Coverage. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $3.7M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -5558.9% ↘

FCF / Share $-6.88

Trailing P/E —

Price / Book 62.7x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 4, 2026.

34-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-4.94M

↓ -14.8% —

FCF / Share Free cash flow per share

$-6.88

↓ -479.0% —

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Invested CapitalReturn on Invested Capital of -279.3% is weak on an absolute basis (target > 10%)
Interest CoverageInterest Coverage of -1047.13x is weak on an absolute basis (target > 5x)
FCF / Net IncomeFCF / Net Income of 0.87x is caution on an absolute basis (target > 1x)

Health Breakdown

Financial Health ↑

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Nov 14, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Nov 8, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Dec 31, 2017 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
EPS Growth YoY (%)	-362.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	-2204.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	4.5% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	-285.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	76.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-546.2% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	84.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-346565.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	57.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-1055.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	—	77.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-1728.6% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	40.0% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-14.8% Weak ↑ Weak Improving Year-over-year change in net income	-87.5% Weak ↓ Weak Declining Year-over-year change in net income	-21.3% Weak ↓ Weak Declining Year-over-year change in net income	-21.3% Weak ↓ Weak Declining Year-over-year change in net income	-21.3% Weak ↓ Weak Declining Year-over-year change in net income	40.9% Excellent ↑ Excellent Improving Year-over-year change in net income	28.1% Excellent ↑ Excellent Improving Year-over-year change in net income	28.1% Excellent ↑ Excellent Improving Year-over-year change in net income	28.1% Excellent ↑ Excellent Improving Year-over-year change in net income	-4.6% Weak ↑ Weak Improving Year-over-year change in net income	-56.5% Weak ↑ Weak Improving Year-over-year change in net income	-77.1% Weak ↓ Weak Declining Year-over-year change in net income	-77.1% Weak ↓ Weak Declining Year-over-year change in net income	-57.9% Weak ↓ Weak Declining Year-over-year change in net income	12.8% Fair → Fair Stable Year-over-year change in net income	22.9% Good ↑ Good Improving Year-over-year change in net income	22.9% Good ↑ Good Improving Year-over-year change in net income	-8.3% Weak ↑ Weak Improving Year-over-year change in net income	-79.7% Weak ↓ Weak Declining Year-over-year change in net income	-46.1% Weak ↑ Weak Improving Year-over-year change in net income	-83.6% Weak ↑ Weak Improving Year-over-year change in net income	-18.9% Weak ↑ Weak Improving Year-over-year change in net income	-850.9% Weak ↓ Weak Declining Year-over-year change in net income	-1069.6% Weak ↓ Weak Declining Year-over-year change in net income	-830.6% Weak ↓ Weak Declining Year-over-year change in net income	61.9% Excellent Excellent Year-over-year change in net income	31.7% Excellent Excellent Year-over-year change in net income	—	—	—	—	—	—	—
FCF Growth YoY (%)	-479.0% Weak Weak Year-over-year change in free cash flow	—	—	—	-224.5% Weak Weak Year-over-year change in free cash flow	—	—	—	85.5% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	-1769.8% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 1 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Nov 14, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Nov 8, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Dec 31, 2017 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
FCF / Net Income (x)	0.94x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.51x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.51x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.24x Good → Good Stable Free cash flow relative to reported net income Optimal: > 1x	0.75x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.72x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—	0.90x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.47x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.98x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.45x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.58x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	1.11x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.00x Caution → Caution Stable Free cash flow relative to reported net income Optimal: > 1x	0.55x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.38x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.48x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.63x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.11x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	0.95x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.98x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.79x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	2.96x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.39x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.02x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Nov 14, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Nov 8, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Dec 31, 2017 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Return on Invested Capital (%)	-5558.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-104.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-25.9% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-14.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-31.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-40.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-132.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	46.5% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	63.2% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	95.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	205.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-129.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-111.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-49.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-35.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-24.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-14.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-41.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-33.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-24.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-25.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-17.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-64.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-52.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-26.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-26.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-255687.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-86.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	21.5% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	30.0% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	38.7% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—	—
Return on Capital (%) (%)	-106.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-69.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-27.4% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-16.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-31.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-36.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-76.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-102.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-213.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-316.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-194.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-62.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-66.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-39.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-28.6% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-17.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-37.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-27.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	-18.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-31.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	-31.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-30.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	—	-131.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-978%)	-43.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-389%)	-32.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-318%)	-39.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-361%)	-51.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-443%)	-105.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-805%)	82.6% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+450%)	80.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+433%)	121.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+709%)	283.3% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+1789%)	-200.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1440%)	-141.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1042%)	-63.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-521%)	-41.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-378%)	-24.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-261%)	-18.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-225%)	-52.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-452%)	-39.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-365%)	-29.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-294%)	-32.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-314%)	-21.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-244%)	-81.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-642%)	-66.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-543%)	-33.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-323%)	-33.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-322%)	—	-56.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-473%)	29.5% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+97%)	—	89.2% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+495%)	—	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Nov 14, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Nov 8, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Dec 31, 2017 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Debt to Equity (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.06x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-90%)	—	—	0.07x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-88%)	0.05x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-92%)	—	—	0.03x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-94%)	—	—	—	—	—	—	—	—	—	—	—	—
Interest Coverage (x)	-814.14x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-2170.46x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1537.52x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-575.72x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-698.72x Weak Weak Operating income divided by interest expense Optimal: > 5x	-12648.41x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	-535.07x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1867.19x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-2466.72x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1102.85x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-906.28x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-2220.82x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-6355.05x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-2212.50x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-1084.09x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1452.88x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-4026.82x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-1619.77x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-963.35x Weak Weak Operating income divided by interest expense Optimal: > 5x	-919.62x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	-697.74x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-92.46x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-55.49x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-26.03x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-19.62x Weak Weak Operating income divided by interest expense Optimal: > 5x	-15.98x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—
Net Debt (USD)	$-2.95M	$-7.20M	$-9.86M	$-12.13M	$-13.05M	$-6.46M	$-6.97M	$-1.49M	$-815.23K	$-548.72K	$-909.55K	$-4.28M	$-5.11M	$-10.06M	$449.87K	$-8.96M	$-12.44M	$-4.58M	$425.99K	—	$-11.08M	$-13.56M	—	—	$-5.38M	$-7.24M	$-630.11K	$-911.93K	$-155.02K	$-282.74K	—	—	—	—
Debt / EBITDA (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-0.13x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	-0.13x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.11x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	-0.16x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Nov 14, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Nov 8, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Dec 31, 2017 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Basic EPS, GAAP (USD)	$-7.30	$-10.15	$-5.76	$-6.42	$-1.58	$460.87	$-0.25	$-6.72	$-0.41	$-12.31K	$-1.08	$-1.04	$-2.59	$-3.55	$-2.56	$-0.09	—	$-16.07	$-0.14	$-0.15	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-6.88	—	$-3.89	$-14.44	$-1.19	—	—	—	$-0.37	—	—	—	$-2.53	—	$-1.36	—	—	—	$-0.07	$-0.20	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.09	$7.15	$17.25	$26.02	$3.73	$52.43	$0.10	$-2.97	$-0.42	—	$-0.41	$0.59	$1.57	$5.03	$5.67	$0.29	$0.37	$6.49	$0.33	$0.49	$0.44	$0.58	—	—	—	$0.46	—	—	—	$-0.04	—	—	—	—
Tangible Book Value per Share (USD)	$0.09	$7.15	$17.25	$26.02	$3.73	$52.43	$0.10	$-2.97	$-0.42	—	$-0.41	$0.59	$1.57	$5.03	$5.67	$0.29	$0.37	$6.49	$0.33	$0.49	$0.44	$0.58	—	—	—	$0.46	—	—	—	$-0.04	—	—	—	—
Basic Weighted Avg Shares (shares)	676,172	—	558,868	370,127	2.73M	—	22.18M	376,643	8.71M	—	4.18M	3.88M	1.91M	—	1.33M	40.03M	—	—	27.44M	25.43M	—	—	—	—	—	—	—	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Nov 14, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Nov 8, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Dec 31, 2017 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Working Capital (USD)	$-504.15K	$4.00M	$9.43M	$12.75M	$10.94M	$6.13M	$3.33M	$-4.62M	$-4.49M	$-4.54M	$-2.01M	$2.07M	$3.05M	$7.64M	—	$10.47M	$13.66M	$4.88M	—	—	$10.88M	$13.59M	—	—	$5.85M	$7.58M	—	—	—	$-644.50K	—	—	—	—
Total Equity (USD)	$70.70K	$4.52M	$9.91M	$13.12M	$10.97M	$6.18M	$3.35M	$-4.29M	$-4.43M	$-4.43M	$-1.74M	$2.45M	$3.49M	$8.13M	$7.57M	$11.52M	$14.80M	$6.16M	$9.10M	$12.41M	$11.24M	$13.95M	$2.47M	$3.72M	$5.88M	$7.60M	$216.00	$377.70K	$-716.78K	$-549.30K	$-347.03K	$-197.84K	$-58.53K	$-58.53K

📋 What is driving earnings? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Nov 14, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Nov 8, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗	Q3 FY2019 Sep 30, 2019 10-Q ↗	Q2 FY2019 Jun 30, 2019 10-Q ↗	Q1 FY2019 Mar 31, 2019 10-Q ↗	Q4 FY2018 Dec 31, 2018 10-K ↗	Q3 FY2018 Sep 30, 2018 10-Q ↗	Q2 FY2018 Jun 30, 2018 10-Q ↗	Q1 FY2018 Dec 31, 2017 10-Q ↗	Q4 FY2017 Dec 31, 2017 10-K ↗
Depreciation Expense (USD)	$1.87K	$1.02K	$697.00	$1.10K	$1.10K	$985.00	—	—	$818.00	$953.00	—	—	$1.28K	$2.38K	$2.79K	—	$3.38K	$3.49K	$3.37K	$3.21K	$3.00K	$3.14K	$3.16K	$2.87K	$1.92K	$1.09K	$698.00	$167.00	$0.00	$0.00	—	—	—	—
Net Income, GAAP (USD)	$-4.94M	$-5.96M	$-4.30M	$-4.30M	$-4.30M	$-3.18M	$-3.54M	$-3.54M	$-3.54M	$-5.38M	$-4.93M	$-4.93M	$-4.93M	$-5.14M	$-3.15M	$-2.78M	$-2.78M	$-3.25M	$-3.61M	$-3.61M	$-3.61M	$-3.00M	$-2.01M	$-2.47M	$-1.97M	$-2.53M	$-211.50K	$-211.50K	$-211.50K	$-6.63M	$-309.70K	—	—	—
Operating Cash Flow (USD)	$-4.65M	$-3.05M	$-2.17M	$-5.34M	$-3.24M	$-5.47M	—	—	$-3.19M	$-2.54M	—	—	$-4.82M	$-2.31M	$-1.81M	—	$-3.08M	$-3.24M	$-2.00M	$-5.00M	$-3.31M	$-1.45M	$-1.27M	$-2.74M	$-1.86M	$-2.48M	$-378.32K	$-616.88K	$-82.69K	$-159.49K	—	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 9 years · 34 quarters

CNS Pharmaceuticals, Inc.

Analytical Summary

34-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Benchmarks unavailable

Compare CNSP with peers